Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

NEC Display Solutions obtains FDA approval for MultiSync diagnostic review monitor

NEC Display Solutions of America has obtained 510(k) approval from the US Food and Drug Administration for its MultiSync MD302C4 LCD, a widescreen display for diagnostic review applications in healthcare organizations.

The MultiSync MD302C4 monitor features a 30-inch IPS panel with four-megapixel resolution. The monitor, which is designed to provide precise color reproduction and wide viewing angles, provides accurate imaging across the screen with its factory-calibrated uniformity control.

The monitor features integrated tri-stimulus (three-color) front sensor, factory adjusted ColorComp digital uniformity correction, factory calibrations to the DICOM grayscale function for luminance, and GammaCompMD QA software.

The device also features a human presence sensor that can automatically dim the screen to conserve power and display life, as well as a Quick QA function for checking DICOM conformance without a computer.

It has an integrated three port USB 2.0 hub with DisplaySync Pro, and DisplayPort, Mini DisplayPort, DVI-D, and HDMI inputs.

NEC Display Solutions professional and medical displays product manager Art Marshall noted that receipt of FDA 510(k) market clearance for the MD302C4 display is the first for an NEC MultiSync Medical Series display with GB-R LED backlight.

"The backlight means up to 44 percent less power consumption for users and complements the enhanced productivity features found in this display," Marshall added.

The MultiSync MD302C4 ships with a five-year limited parts and labor warranty, including Advanced Overnight Exchange.